Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but also how technology has allowed for quick and now cheap ways of mapping ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

In this episode of the Applied Clinical Trials Brief, Shipra Patel, global therapeutic area section head for endocrinology ...

In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2. “In ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and ...

Queen Mary researchers led by Dr. Emanuel Rognoni and Dr. Matthew Caley, with backing from DEBRA Research, have begun a new ...

BUFFALO, N.Y. – The Empire Discovery Institute has entered into a collaborative research partnership with the National Multiple Sclerosis Society and its commercial development program Fast Forward, ...

Three scientists who helped in developing the cystic fibrosis drug that extends life by decades have won the prestigious ...